The survival benefit of combination chemotherapy to patients with advanced non-small-cell
carcinoma of the lung (NSCLC) is controversial. To study this question, the National Cancer …

Background: Cancer Care Ontario's Systemic Therapy Task Force recently reviewed the
medical oncology system in the province. There has been growing concern about anecdotal …

… Shepherd Collection and assembly of data: Katherine MW Pisters, William K. Evans,
Mark G. Kris, Christopher A. Smith, Christopher E. … Uchitomi Y, Mikami I, Nagai K, et al …

Introduction: Thymoma is a rare tumor for which there is little randomized evidence to guide
treatment. Because of the lack of high-quality evidence, a formal consensus-based approach …

Introduction Non-small cell lung cancer (NSCLC) frequently presents at an incurable stage,
and a majority of patients will be considered for palliative chemotherapy at some point in …

PURPOSE To present an update on the development of oncology practice guidelines (PGs)
using the Practice Guidelines Development Cycle (Cycle), and to present the results of …

Background: Among patients with early-stage non–small cell lung cancer (NSCLC),
preoperative imaging tests are important in defining surgical candidates. Objective: To assess …

Background Results from retrospective studies indicate that selecting individuals for low-dose
CT lung cancer screening on the basis of a highly predictive risk model is superior to using …

Background: There is an increasing demand for oncology care as a result of a number of
trends. In combination with ongoing changes to the health‐care system, these trends have an …

Introduction Patients with non-small cell lung cancer (NSCLC) require careful preoperative
staging to define resectability for potential cure. Fluorodeoxyglucose positron emission …